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Abstract
Background: The usage of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for the diagnosis of
solid pancreatic cancer is increasing, however mainly retrospective studies are available about the detailed methods
of sampling.
Methods: To compare prospectively the diagnostic yield of EUS-FNA samples obtained with slow-pull (SP) and with
standard suction technique (SS).
Results: EUS-FNA sampling was diagnostic in 72 of 92 cases (78.3%). Diagnostic yield was 67.4% in the SS and 65.
2% in the SP group. The number of smear pairs (1.84 vs. 3.56; p < 0.001) and blood contamination (1.50 vs. 2.19;
p < 0.001) were significantly higher in the SS group, which resulted in lower rate of diagnostic samples (41.8% vs.
30.0%; p = 0.003). There was no difference in the cellularity (1.58 vs. 1.37; p = 0.2554), or in the sensitivity and
specificity in the identification of malignancy between SP and SS subgroups (69.9, 100% vs. 73.5, 100%). Histological
samples were obtained in 60 cases (with SP: 49 cases; with SS: 46 cases). There was no difference in the diagnostic
yield of histological samples between the groups (63 and 58.7%).
Conclusion: The diagnostic yield, the cellularity of smears and the rate of acquiring sufficient histological material
are similar in the SP and SS group, but due to lower bloodiness and decreased number of slides, the pathological
diagnosis is faster and more cost-effective.
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BACKBROUND
Endoscopic ultrasound-guided fine needle aspiration
(EUS-FNA) is an accurate and safe diagnostic modality,
which by now has become the first line sampling procedure
for the histological/cytological diagnosis of solid pancreatic
cancer [1, 2]. The diagnostic yield of EUS-FNA in differen-
tiating benign and malignant pancreatic lesions varies
widely, and it is substantially influenced by the experience
of the endosonographer and the pathologist, the tumor
characteristics, sampling technique, processing of smears
[3]. The pooled sensitivity and specificity of malignant cy-
tology is 83–95% and 71–100%, respectively [4, 5].
Despite the increasing use of EUS-FNA, there are no
evidence-based recommendations about the detailed
technique and processing of smears, therefore, they vary
substantially across medical centers. The optimal sam-
pling technique is expected to produce samples of satis-
factory quality with high cellularity and low blood
contamination [6]. The high number of smears is one of
major limitations of EUS-FNA, because it increases costs
and the length of pathological evaluation. These quality
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features are influenced by the vascularity and stiffness of
the tumor, as well as by the needle and suction charac-
teristics. The suction force for sampling can be gener-
ated by multiple different ways. The slow pull out of
stylet during the sampling generates a small suction/ca-
pillary force (stylet slow-pull technique; SP). In contrast,
greater suction/vacuum is created attaching a 5 or 10
mL syringe to the hub of the needle after quick removal
of the stylet (standard suction; SS). In addition, many
subtypes of the two techniques are known based on the
duration (constant, intermittent) and/or the strength of
suction force, and how it has been created (with vacuum
syringe or manually). The technical guideline of
European Society of Gastrointestinal Endoscopy (ESGE)
recommends continuous suction for EUS-FNA of pan-
creatic solid masses and cystic lesions [7, 8]. Recently
published comparison studies are questioning this,
although their results are contradictory. Some studies
suggest that the quality of smears obtained by SP is bet-
ter compared with SS, but others disprove this [9–11].
Therefore, the aim of our prospective study was to
compare the diagnostic yield of EUS-FNA samples
obtained by SS and SP in patients with suspected malig-
nant pancreatic lesions based on the number of diagnos-
tic smear pairs, bloodiness and cellularity.
Methods
This prospective comparison study was carried out be-
tween January 2014 and June 2016 in a tertiary level
referral medical center with collaboration between the
pathology and gastroenterology department. 92 patients
were enrolled who underwent EUS-FNA sampling due
to suspected pancreatic cancer. The inclusion criteria
were the following: 1) previously identified solid pancre-
atic lesions by cross-section imaging modalities which
were suspicious for malignancy; 2) unresectable disease
due to local invasion, dissemination to distant organs,
severe comorbidity or poor general condition of the
patient, or cases when the patient did not consent to
surgery; 3) the cytological or histological verification of
pancreatic cancer was necessary for the selection of ad-
equate further therapy.
The study was approved by the Regional and Institutional
Human Medical Biological Research Ethics Committee of
the University of Szeged (ethics approval number: 3679
SZTE). The study is carried out under the declaration of
Helsinki.
EUS-FNA sampling, preparation of specimens
EUS-FNA examinations were performed by the same two
investigators under intravenous premedication with 5–15
mg midazolam, 20mg butylscopolamine and 10–20mg
nalbuphine. Linear echoendoscope (Olympus GF-UCT
140; Olympus GF-UCT 160; Olympus Optical, Tokyo,
Japan) and 22G FNA needles (Echotip Ultra; Cook Ireland
Ltd., Limerick, Ireland; EZ Shot 2, Olympus Optical,
Tokyo, Japan) were applied for the sampling. After the de-
termination of the optimal puncture site, the needle was
inserted under continuous real-time ultrasound guidance
to the target lesion and approximately 10 to 15
back-and-forth movements were done in a fanning man-
ner. 2–2 punctures using SP and SS technique were pro-
posed to be carried out with the same needle from the
same lesion, but reduction or increase of the punctures’
number was allowed if the examiner considered it neces-
sary based on the quality of the obtained specimen. In
case of SP, suction force is generated by the slow pull out
of stylet during the back-and-forth movements of needle.
In case of SS technique, 5 ml syringe was attached to the
hub of the needle after quick removal of the stylet to cre-
ate greater suction force compared to SP. The puncture
was considered technically successful if it yielded any
grossly or microscopically identifiable cells or tissue frag-
ments regardless of their diagnostic value. It means that
the suction force was strong enough for mobilizing cellu-
lar material from the target organ. The aspirated specimen
was expressed onto glass slides by reinserting the stylet
into the needle. The prepared smears were fixed in 96%
methanol at least for 10min. The grossly visible, whitish,
yellowish or reddish pieces of tissue were placed in 10%
buffered formalin. After the repeated removal of the stylet,
the residual aspirated material was flushed out from the
needle with saline and 5ml air to a native sampling tube.
This procedure flushed out the residual specimen from
the needle. Rapid on-site evaluation (ROSE) was
unavailable.
After EUS-FNA sampling, patients were closely ob-
served for 24 h, and blood samples were taken for detec-
tion of procedure related complications (elevated
amylase level, acute pancreatitis, infection, bleeding,
etc.).
Pathological assessment
All cytological smears were stained by hematoxylin-
eosin (HE); immunocytochemistry was performed only
in selected cases on smears with high cellularity. The
fluid in the native sampling tube obtained by flushing
the EUS-FNA needle with saline was centrifuged, and
smears or paraffin-embedded cell block samples were
prepared. The quality of smears was assessed based on
the semiquantitative scale of bloodiness and cellularity
(Table 1), furthermore the number of diagnostic slide
pairs was determined. The formalin-fixed and
paraffin-embedded (FFPE) tissues were processed using
the standard protocol for endoscopic biopsies: standard
staining with HE supplemented by mucin stain (periodic
acid-Schiff reaction after Alcian blue staining, pH 2.5,
PAB) and immunohistochemical testing (CK7, CK20,
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MUC5AC, CDX-2, chromogranin A, synaptophysin,
etc.). The efficiency and diagnostic value of EUS-FNA
sampling was determined based on the classification of
Papanicolaou Society [12]. (Table 2) The sampling was
considered diagnostic if it clearly confirmed the presence
of non-neoplastic (Papanicolaou II. category) or neoplas-
tic pancreatic lesion (Papanicolaou IV., and VI. categor-
ies), or when the cytopathologist had a high degree of
certainty of the presence of carcinoma in clinically un-
equivocally malignant-appearing tumors (Papanicolaou
V. category).
Data collection and statistics
The medical documentation of patients was collected
using MedSolution medical recorder. Statistical analysis
was performed using SPSS software version 22 (SPSS Inc.,
Chicago, Illinois, USA) and SigmaPlot 12.5 (Systat Soft-
ware Inc., San Jose, California, USA). Values of p < 0.05
were considered significant. The differences in the bloodi-
ness, cellularity, number of smear pairs per puncture and
diagnostic smear pairs between the SS and SP group were
compared using paired sample t-tests and Mann-Whitney
Rank Sum Test. We used logistic regression analysis,
Fisher’s exact test and Chi Squared test to identify the fac-
tors that can modify the effectiveness of sampling.
Descriptive statistics were expressed as mean and median
with ranges.
Results
Characteristics of patients and sampling
92 EUS-FNA sampling of 89 patients were involved be-
tween January 2014 and June 2016. Sampling had to be
repeated in three patients due to non-diagnostic smears.
There was no significant proportional variance with re-
gard to the patients’ gender: male-female ratio was
38:51. Mean age at time of sampling was 66.1 years
(range 27–95; median 69). Lesions were located most
frequently in the pancreatic head (N = 71; 79.8%). The
mean diameter was 31.8 mm (range 7–62; median 30),
and in 44 cases (47.2%) cancer antigen 19–9 (CA19–9)
was elevated. The characteristics of patients and
EUS-FNA examinations are summarized in Table 3.
There was no significant difference between the use of
Cook Medical and Olympus EZ Shot 2 needles (47 vs.
55 cases). The mean number of passes for each lesion
was 4 (3–7; median 4).
Comparison of diagnostic yield of EUS-FNA sampling
using SS and SP
EUS-FNA sampling was diagnostic in 72 cases (78.3%):
the presence of neoplasm was confirmed in 69 cases
(Papanicolaou IV, V, VI) and chronic pancreatitis in 3
cases (Papanicolaou II). (Fig. 1) There was no significant
difference between the diagnostic yield of SP and SS
(65.2% vs. 67.4%), although the technical success rate
was higher in the SS group (92.4% vs. 100%), but it was
not statistically relevant. (Table 4) Cytological examin-
ation of the fluid obtained by flushing the needle with
saline confirmed the diagnosis in 31 cases (33.7%), and
in one patient the diagnosis was based only on this cyto-
logical sample. Figure 2 shows the distribution of diag-
nostic slides between the three techniques (flushing the
Table 1 Bloodiness of smears
Cellularity of smears
0 - Acellular No or only a few tumor cells
1 – Low < 2 clusters of malignant cells with a minimum 10
tumor cells
2 – Medium 2-4 clusters of malignant cells with a minimum 10 tumor
cells
3 – High > 4 clusters of malignant cells with a minimum 10 tumor
cells
Bloodness of smears
0 - Absence No or minimal blood contamination
1 – Mild A few blood cells which do not interfere with
pathological evaluation
2 – Moderate Partially covered by blood cells, but pathological
evaluation is possible
3 – Severe Covered by blood cells which interfere with pathological
evaluation
Table 2 Classification of Papanicolaou Society for assessment
of cytological sampling of the pancreatobiliary system.
(NET - neuroendocrine tumor; IPMN - intraductal papillary
mucinous neoplasm; MCN - mucinous cystic neoplasm)
Papanicolaou society of cytopathology system for reporting
pancreaticobiliary cytology
I. Non-diagnostic
II. Negative (for
malignancy)
Benign pancreatic tissue
Acute, chronic or autoimmune pancreatitis
Pseudocyst, lymphoepithelial cyst
Splenule/accessory spleen
III. Atypical
IV. Neoplastic - Benign Serous cystadenoma
Neuroendocrine microadenoma
Lymphangioma
IV. Neoplastic - Other Well-differentiated NET
IPMN, all grades of dysplasia
MCN, all grades of dysplasia
Solid-pseudopapillary neoplasm
V. Suspicious (for
malignancy)
VI. Positive or Malignant Ductal adenocarcinoma of the pancreas and
its variants
Cholangiocarcinoma
Acinar cell carcinoma
Poorly differentiated (small and large cell) NET
Pancreatoblastoma
Lymphoma
Metastatic malignancy
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needle, SS and SP). Histological samples were taken in
60 cases with similar efficiency in the SS and SP
group (50.0% vs. 53.3%). There was no detectable dif-
ference between the two groups in the diagnostic
yield of histological samples (58.7% vs. 63.2%). The
diagnostic yield of EUS-FNA examination was not in-
fluenced by the endosonographer, the needle type,
tumor size and location.
The average number of smear pairs for one pass was
significantly higher in the SS group (3.56; range 1–9.5;
median 3.5) compared with the SP one (1.84; range 0–
7.5; median 1.5), but it was associated with considerably
increased bloodiness (1.50 vs. 2.19; p < 0.001). Cellularity
did not differ statistically between the groups (1.58 vs.
1.37; p = 0.2554). In contrast, the proportion of diagnos-
tic smears obtained with SP was higher (41.8% vs. 30.0%;
p = 0.003). (Fig. 3-4).
Complications
Early complication occurred in three cases (3.2%). A
66-year old man developed mild, postprocedural acute
pancreatitis, which recovered during 4-days long total
parenteral nutrition. Two patients had threefold eleva-
tion in serum amylase level without clinical symptoms.
Severe and late complications were not found.
Follow-up of patients
In 69 of 72 diagnostic EUS-FNA samplings pathological
examination demonstrated neoplastic pancreatic lesions.
Ductal adenocarcinoma was the most frequent neoplasm
with 64.1% incidence rate. Five low grade and one high
grade neuroendocrine tumors (NET) were identified (6.5%).
The latter was proved to be ductal adenocarcinoma by aut-
opsy. On one occasion signet ring cell carcinoma was
found. Repeated histological sampling (5 autopsies, 8
Table 3 Baseline characteristics of patients and sampling (CA19–9 – carcinoma antigen 19–9; CgA – chromogranin A; LMWH – low
molecular weight heparin; PAI – platelet aggregation inhibitors)
Patients (N = 89) Sampling (N = 92)
Male/female 38/51 Examiners: Z.Sz/L.Cz 70/22
Age (year) 66.1
(27–95; median: 69)
Punctures per examination 4 (3–7; median: 4)
Tumor location 3 2 punctures
4 punctures
5 punctures
6 punctures
7 punctures
23 (25%)
47 (51.1%)
17 (18.5%)
6 (4.3%)
1 (1.1%)
Head
Body
Tail
Diffuse
71 (79.8%)
7 (7.9%)
8 (8.9%)
3 (3.4%)
Tumor size (mm) 31.8
(7–62; median: 30)
LMWH
PAI
10 (10.9%)
14 (15.2%)
CA 19–9
Elevated
Normal
No data
CgA elevation
44 (47.2%)
27 (29.3%)
18 (19.5%)
5 (5.6%)
Needle type
Echotip
EZ Shot 2
37 (40.2%)
55 (59.8%)
Fig. 1 Efficacy of sampling according to the classification of Papanicolaou Society. Grey color shows the non-diagnostic and black the diagnostic categories
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surgical samples, 2 transabdominal core biopsies) con-
firmed the results of EUS-FNA in 14 cases, and in the rest
55 cases the clinical course affirmed the diagnosis. In a case
of chronic pancreatitis based on the FNA results, Whipple
procedure was performed due to biliary obstruction. Patho-
logical evaluation of the surgical specimen revealed pancre-
atic intraepithelial neoplasia 1B (PanIN-1B) besides chronic
pancreatitis.
In 5 out of 14 non-diagnostic EUS-FNAs (Papanico-
laou I) benign disease was detected by further exami-
nations (1 autoimmune and 3 chronic pancreatitis; 1
infection). In the rest 9 cases ductal adenocarcinoma
(N = 5), biliary duct carcinoma (N = 1), intraductal
papillary mucinous neoplasm (IPMN; N = 1) and
metastatic renal cell carcinoma (N = 2) were identified.
In the background of atypia benign disorder was
found only in one case (autoimmune pancreatitis).
Based on the results of follow-up the sensitivity, speci-
ficity, negative predictive value (NPV), positive predict-
ive value (PPV) and accuracy of EUS-FNA sampling in
the identification of pancreatic neoplasm were 83.1, 100,
39.1, 100 and 84.8%, and no detectable difference was
found between the SP and SS groups (69.9, 100, 26.5,
100 and 84.8% vs. 73.5, 100, 29, 100 and 76.1%).
(Table 5).
Discussion
Only few studies with contradictory results have been
published which assessed the diagnostic yield and the
quality of smears obtained by EUS-FNA of solid pancre-
atic masses using SS and/or SP. The important advantage
of our prospective study is the use of standardized condi-
tions. The sampling efficacy of the two techniques was
assessed in the same lesions; therefore, there was no dif-
ference in the tumor characteristics (size, location, vascu-
larity, stiffness) and in the diagnostic process
(premedication, endoscope, needle type and diameter,
endosonographer, assistant, pathologist, etc.).
The diagnostic accuracy of EUS-FNA sampling was
78.3%. No difference was found between the two tech-
niques (SS: 67.4% vs. SP: 65.2%); but higher diagnostic
accuracy could be achieved with the combination of the
techniques than with one technique alone. These results
correlate with previous studies. The retrospective obser-
vational study carried out Touchefeu et al. followed 100
consecutive patients with suspected malignant pancre-
atic masses, and concluded that EUS-FNA provides ac-
curate diagnosis in about 80% of cases, and its results
directly influenced the management strategy in 62% of
cases [13]. The meta-analysis of Hewitt et al. assessed
the data of 4984 EUS-FNA examination from 33 papers,
and found that the pooled sensitivity and specificity of
malignant cytology is 85% (95% CI, 84–86) and 98%
(95% CI, 97–99), respectively [4]. Previous trials also
suggest that the efficacy of EUS-FNA sampling could be
influenced by the sampling process and the type of suc-
tion. The results of two prospective studies showed that
capillary technique with 22G needle improves the histo-
logical quality of samples, which is manifested in a
higher proportion of tissue microfragments, but does
not result in elevated diagnostic accuracy compared with
suction technique [9, 14]. In contrast, Puri et al. found
significantly higher sensitivity and negative predictive
value when suction technique with 22G needle was ap-
plied (85.7% vs. 66.7%), but it was also associated with
increased number of slides (17.8 ± 7.1 vs. 10.2 ± 5.5; p =
0.001) and higher blood-contamination [10]. The study
performed by Lee et al. also confirmed these results.
They assessed the results of 324 punctures from 81 pa-
tients and found significantly higher diagnostic yield
(85.2% vs. 75.9%; p = 0.004), sensitivity (82.4% vs. 72.1%;
p = 0.005), cellularity (p < 0.001) and
blood-contamination (p < 0.001) in the suction group,
with no difference in terms of specificity (96.8% vs.
100%). The substantial disadvantage of this study was
the lack of distinction between the 22G and 25G needles
[15]. Nakai et al. detected a difference between capillary
Table 4 Comparison of standard suction and stylet capillary
technique
Capillary Technique Standard Suction
Technical success rate 85 (92.4%) 92 (100%)
Diagnostic yield 60 (65.2%) 62 (67.4%)
Histological sample obtained 49 (53.3%) 46 (50.0%)
Diagnostic yield of histological
sample
31 (63.2%) 27 (58.7%)
Fig. 2 Venn diagram: distribution of diagnostic samples obtained by
the flushing of the needle, SS and SP techniques
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and suction technique only when 25G needle was ap-
plied (90% vs. 67%) [16]. Dabizzi et al. also found signifi-
cantly superior adequacy rate with capillary technique
compared with suction (aspiration) technique using a
25G needle (80% vs. 97%; p = 0.04), but they provided
similar results in cellularity and blood amount [17]. Irre-
spective of the sampling technique, previous publica-
tions suggested that the 25G needle would be more
effective than the 22G one [18–20]. A meta-analysis
assessing data of 1292 patients found higher sensitivity
in cases when 25G needle was used compared with the
22G needle (93% vs. 85%), but the specificity was similar
(97% vs. 100%) [5]. In our study we used only 22G nee-
dles, and we detected significantly higher blood contam-
ination and lower cellularity in the SS group, but the
technical success rate and the diagnostic accuracy did
not show statistically relevant difference.
Immunohistochemistry is often essential for the accur-
ate diagnosis of nonmalignant lesions and for precise
subtyping of uncommon pancreatic neoplasms, such as
Fig. 3 The mean number of smear pairs per puncture obtained by standard suction was significantly higher (p < 0.001) and the proportion of
diagnostic slides was lower compared whit stylet capillary technique (p = 0.003)
Fig. 4 There was no difference between the cellularity of smears obtained by stylet capillary technique and standard suction, but the bloodiness
was significantly higher in the standard suction group (p < 0.001)
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mesenchymal, neuroendocrine, solid pseudopapillary tu-
mors or metastases. Contrary to the conventional
smears, which usually yield only limited material avail-
able for ancillary techniques, FFPE tissue blocks allow
multiple sections to be cut from it allowing multiple
immunostains. In our study, histological samples could
be obtained in 65.2% of the cases with similar propor-
tion in the SS and SP groups (50.0% vs. 53.3%). The dis-
tinction between tissue fragments and coagulum based
on the macroscopic appearance was not possible in the
majority of the cases; therefore, in most of nondiagnostic
cases formalin fixed samples contained only red blood
cells. The diagnostic accuracy of tissue samples was
66.7%, which is consistent with the results of previous
publications [21]. In a prospective study carried out by
Kida et al. the tissue sampling rate for histology was
83% with a diagnostic accuracy of 85%, which was not
influenced by the needle size (22G 58%; 25G: 56%). Des-
pite the significantly higher sampling rate for cytology,
the diagnostic accuracy of histology and cytology did not
differ significantly from each other: they were 66 and
75% with the 22G needle vs. 73 and 60% with the 25G
needle [22]. Park et al. concluded that combined analysis
is more sensitive than cytology and histology alone
(81.8% vs. 69.8% vs. 67.2%; p < 0.01) [23]. Hucl et al.
showed that the average number of passes to obtain suf-
ficient tissue is significantly lower when 22G ProCore
needles were used compared with the standard 22G nee-
dles (1.2 ± 0.5 vs. 2.5 ± 0.9; < 0.001) [24], but the diagnos-
tic accuracy did not show relevant difference in the two
groups [25]. Vanbiervliet et al. confirmed these results,
and additionally found that the overall sample quality
was significantly better in case of standard 22G needle
[26]. Our previous experiences did not confirm the su-
periority of ProCore needles compared with the standard
needles, therefore we used them only in case of suspi-
cious autoimmune pancreatitis, neuroendocrine and
stromal tumors.
The higher cost compared to transabdominal sampling
is one of the important disadvantages of EUS-FNA. The
price of the endoscopic ultrasound system and the
needles in themselves are outstandingly high; the rela-
tively high number of stained smears further increases
the overall costs. The technique which reduces the num-
ber of samples without impairing the accuracy could
make EUS-FNA sampling more cost-effective. Rapid
on-site evaluation (ROSE) may be a good alternative. It
could result up to 3.5–15% improvement in adequacy
rates and accuracy of the cytological examination, and it
could help to reduce the number of EUS-FNA passes
and slides, which could further shorten the length of
examination and pathological evaluation [13, 27–29].
Fabbri et al. found that tissue samples obtained by Pro-
Core needles could achieve comparable adequacy and
diagnostic accuracy with rapid on-site evaluation (ROSE)
[30], and it could be more cost-effective [31]. ROSE was
not available during the study period in our department,
and previously we did not experience better adequacy
rates with ProCore needles. However, capillary technique
resulted in significantly lower number of smears without
any impairment in cellularity and diagnostic yield.
The complication rate of EUS-FNA is approximately
1%, and includes infection, bleeding, and acute pancrea-
titis [7, 32]. In our study it was slightly higher (3.2%),
but in two cases the elevation of serum amylase level
was not accompanied by clinical symptoms of pancrea-
titis, and only one patient had mild, acute pancreatitis
(1.1%). Based on these results, our study confirmed the
safety of EUS-FNA sampling.
The relatively small number of enrolled cases was a
major limiting factor. Not being a randomized controlled
trial is another drawback of our study. The order of
techniques was not randomized, SCT was performed
first in all of the cases, which could possibly influence
the smears’ quality – this effect might have been avoided
with randomization.
Conclusion
This study revealed that SP is an effective method with
an outstanding technical success rate and efficacy com-
pared to SS in the EUS-FNA sampling of pancreatic le-
sions. Cellularity of smears and the rate of acquiring
sufficient histological material are similar with SS; how-
ever, lower bloodiness of samples and decreased number
of slide pairs may result in faster pathological diagnosis
and more cost-effectiveness in case of SP. Thus, we rec-
ommend SP as the first sampling method of solid pan-
creatic lesions. It may further be supplemented by SS in
case no tissue fragments could be obtained or when the
macroscopic appearance of the samples suggests their
inappropriateness for the diagnosis based on the consid-
eration of the endosonographer.
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